Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
The glucocorticoid-induced osteoporosis International Guidelines provide the following recommendations for the prevention and treatment of non-pharmacological treatment of glucocorticoid-induced osteoporosis: minimise the use and dosage of glucocorticoids as much as possible; all patients are advised to undergo a fall risk assessment and to abstain from smoking and alcohol; exercise that improves strength and balance of the lower limbs, as appropriate, is recommended to reduce the risk of fracture; patients treated with long-term glucocorticoids should be monitored for their daily intake of calcium and vitamin D.
Source: 3.4.1. Non-pharmacological treatment. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Advances in the study and treatment of glucocorticoid osteoporosis: A review
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Advances in the study and treatment of glucocorticoid osteoporosis: A review
Review / evidence synthesis · Medicine · 2025
Original publication title
Advances in the study and treatment of glucocorticoid osteoporosis: A review
Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
In recent years, the widespread application of glucocorticoids in the medical field has led to a notable rise in the incidence of glucocorticoid-induced osteoporosis (GIOP). Currently, glucocorticoid-induced osteoporosis has emerged as the third leading cause of osteoporosis, following senile osteoporosis and postmenopausal osteoporosis. Scientific investigations have demonstrated that glucocorticoids exert a dual-pronged negative impact on bone metabolism. On one hand, glucocorticoids inhibit osteoblasts proliferation, trigger osteoblasts apoptosis, and undermine their osteogenic potential. On the other hand, glucocorticoids enhance osteoclasts proliferation and extend osteoclasts lifespan.
Additionally, glucocorticoids can indirectly impede osteogenic differentiation by disrupting the balance of relevant cytokines and compromising the blood supply to bone tissue. This article is a comprehensive review of the latest research findings and treatment advances in the field of glucocorticoid-induced osteoporosis.
Authors’ abstract
In recent years, the widespread application of glucocorticoids in the medical field has led to a notable rise in the incidence of glucocorticoid-induced osteoporosis (GIOP). Currently, glucocorticoid-induced osteoporosis has emerged as the third leading cause of osteoporosis, following senile osteoporosis and postmenopausal osteoporosis. Scientific investigations have demonstrated that glucocorticoids exert a dual-pronged negative impact on bone metabolism. On one hand, glucocorticoids inhibit osteoblasts proliferation, trigger osteoblasts apoptosis, and undermine their osteogenic potential. On the other hand, glucocorticoids enhance osteoclasts proliferation and extend osteoclasts lifespan.
Additionally, glucocorticoids can indirectly impede osteogenic differentiation by disrupting the balance of relevant cytokines and compromising the blood supply to bone tissue. This article is a comprehensive review of the latest research findings and treatment advances in the field of glucocorticoid-induced osteoporosis.
Publication and source details
Original title: Advances in the study and treatment of glucocorticoid osteoporosis: A review
Xingyu Song; Yaheng Zhang; Hongtao Yang; Fujun Xiong; FengFeng Chen
Medicine · 2025
* Correspondence: Xingyu Song, Department of Orthopaedics, Xi’an Daxing Hospital, No. 353 Laodong North Road, Lianhu District, Xi’an 710082, Shaanxi Province, China (e-mail: 2657340736@qq.com).Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.2025https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T05:25:13.204137+00:00
DOI: 10.1097/md.0000000000042668 · PMC12129549